Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,316.40
(
0.36%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
93.52
(
-3.58%
)
Bitcoin
75,877.55
(
0.04%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

p3analyze

Send PM Follow Ignore
Followers 9
Posts 957
Boards Moderated 0
Alias Born 07/16/2006

p3analyze

Re: iwfal post# 145738

Thursday, 07/19/2012 11:35:38 AM

Thursday, July 19, 2012 11:35:38 AM

Post# of 257644

Do you have a cite (for percentage of PD events that are new lesion among NSCLC patients treated with docetaxel)?



No cite. Based on my experience working with oncology trials, it should be less than 10%, although that percentage could be higher among patients with short PFS duration as discussed in the first reply.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today